Pathomation was born in November 2012 as a spinoff of the CRO HistoGeneX, which is located in Antwerp (Belgium) and has established a strong reputation in the pharma industry. HistoGeneX offers high quality histology, pathology, and molecular diagnostic services for pharmaceutical and hospital customers.
Back in 2012, no satisfying software solutions were available on the market to establish a fully digitized controlled workflow using digitally scanned glass slides within the HistoGeneX lab. Pathomation was founded to answer these needs.
All Pathomation software was co-developped in close collaboration with the HistoGeneX practicing pathologists, aiming to meet the highest quality standards and user friendliness. Pathomation software is currently up and running within the Histogenex workflow.
Pathomation strongly believes that digital pathology will reduce laboratory expenses, boost operational efficiency, enhance productivity, aid in better treatment decisions and ultimately improve patient care. We are convinced that digital pathology is the future for diagnostic consultations, primary and intraoperative diagnosis, medical student education, resident training, diagnostic decision support, peer review, manual and semi quantitative review of immunohistochemistry (IHC), and tumor boards.
Pathomation is a leading innovator of software solutions in the digital pathology domain, providing software solutions with emphasis on communication and interoperability solutions for the end users.